Home › Funds › THIRD AVENUE MANAGEMENT LLC › COLL
THIRD AVENUE MANAGEMENT LLC position in COLL
COLLEGIUM PHARMACEUTICAL INC · Health Care
THIRD AVENUE MANAGEMENT LLC reported holding 222,738 shares of COLL (COLLEGIUM PHARMACEUTICAL INC) in its Q3 2026 13F filing — a position valued at US$4.9M, representing 0.82% of its reported portfolio and ranking #37 among its reported holdings. THIRD AVENUE MANAGEMENT LLC has disclosed COLL holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How THIRD AVENUE MANAGEMENT LLC's COLL position evolved
THIRD AVENUE MANAGEMENT LLC first disclosed a stake in COLL in Q4 2023 at 83,120 shares (US$2.6M). The position peaked in Q4 2025 at 203,401 shares, worth US$9.4M. Across 12 filings, THIRD AVENUE MANAGEMENT LLC increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 222,738 shares valued at US$4.9M — an increase of 40,093 shares quarter over quarter.. Notable position changes include a 30% increase in Q1 2024 (shares fell 17% over the following quarter), a 69% increase in Q2 2024 (shares rose 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 83.12K | $2.56M | New |
| Q1 2024 | 108.12K | $4.20M | Add |
| Q2 2024 | 182.28K | $5.87M | Add |
| Q3 2024 | 182.65K | $7.06M | Hold |
| Q4 2024 | 203.40K | $5.83M | Add |
| Q1 2025 | 203.40K | $6.07M | Hold |
| Q2 2025 | 203.40K | $6.01M | Hold |
| Q3 2025 | 203.40K | $7.15M | Hold |
| Q4 2025 | 203.40K | $9.42M | Hold |
| Q1 2026 | 155.14K | $5.13M | Reduce |
| Q2 2026 | 182.65K | $6.61M | Add |
| Q3 2026 | 222.74K | $4.86M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About COLL and 13F data
COLL (COLLEGIUM PHARMACEUTICAL INC) is a Health Care company. 29 other funds we track also report a position in COLL — the largest reported positions include TENOR CAPITAL MANAGEMENT Co., L.P. (US$85.8M), EVENTIDE ASSET MANAGEMENT, LLC (US$49.3M), GOLDENTREE ASSET MANAGEMENT LP (US$26.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COLL
- TENOR CAPITAL MANAGEMENT Co., L.P. 68.81M sh · $85.79M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.36M sh · $49.27M · Q2 2026
- GOLDENTREE ASSET MANAGEMENT LP 744.89K sh · $26.92M · Q2 2026
- SILVERBACK ASSET MANAGEMENT LLC 15.30M sh · $18.79M · Q2 2026
More on THIRD AVENUE MANAGEMENT LLC
FAQ
How long has THIRD AVENUE MANAGEMENT LLC held COLL?
THIRD AVENUE MANAGEMENT LLC has disclosed COLL holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is THIRD AVENUE MANAGEMENT LLC's current position in COLL?
As of Q3 2026, THIRD AVENUE MANAGEMENT LLC holds 222.74K shares of COLL (COLLEGIUM PHARMACEUTICAL INC), valued at $4.86M, representing 0.82% of its reported portfolio and ranking #37.
Has THIRD AVENUE MANAGEMENT LLC been buying or selling COLL?
In the latest 13F filing (Q3 2026), THIRD AVENUE MANAGEMENT LLC increased its position in COLL. The position peaked in Q4 2025 at 203.40K shares.
Which other funds hold COLL?
Other major institutional holders of COLL include TENOR CAPITAL MANAGEMENT Co., L.P., EVENTIDE ASSET MANAGEMENT, LLC, GOLDENTREE ASSET MANAGEMENT LP, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.